Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference11%
- Check21 days agoChange DetectedUpdate: version bump from v3.0.2 to v3.1.0. No substantive content changes detected.SummaryDifference0.3%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision is updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.6%
- Check42 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.6%
- Check50 days agoChange DetectedThe web page has undergone significant changes, including the termination of a study and updates to its status and results. Key details such as facility name and location have been added, while previous location-related terms and statuses have been removed.SummaryDifference32%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.